Blincyto (blinatumomab) - Amgen
Jakafi (ruxolitinib) - Incyte
cyclophosphamide - Generic mfg.
FORUM2: Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL (clinicaltrials.gov) - Oct 21, 2026 - P2/3 | N=1000 | Recruiting | Sponsor: Bambino Gesù Hospital and Research Institute | Not yet recruiting ➔ Recruiting 
Enrollment open • Acute Lymphocytic Leukemia • Bone Marrow Transplantation • Graft versus Host Disease • Hematological Malignancies • Leukemia • Oncology • Pediatrics • Transplantation
http://clinicaltrials.gov/ct2/show/NCT07297914
 
Oct 21, 2026
 
Prev Next